Repligen Corp. (RGEN)
176.25
-5.78
(-3.18%)
USD |
NASDAQ |
Aug 28, 16:00
176.25
0.00 (0.00%)
After-Hours: 17:48
Repligen Cash from Operations (Quarterly) : 32.77M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 32.77M |
| March 31, 2026 | 28.30M |
| December 31, 2025 | 25.70M |
| September 30, 2025 | 48.10M |
| June 30, 2025 | 28.61M |
| March 31, 2025 | 15.00M |
| December 31, 2024 | 39.18M |
| September 30, 2024 | 49.32M |
| June 30, 2024 | 42.19M |
| March 31, 2024 | 44.71M |
| December 31, 2023 | 29.06M |
| September 30, 2023 | 39.23M |
| June 30, 2023 | 34.47M |
| March 31, 2023 | 11.15M |
| December 31, 2022 | 61.88M |
| September 30, 2022 | 41.37M |
| June 30, 2022 | 45.72M |
| March 31, 2022 | 23.11M |
| December 31, 2021 | 49.62M |
| September 30, 2021 | 22.48M |
| June 30, 2021 | 37.65M |
| March 31, 2021 | 9.262M |
| December 31, 2020 | 14.87M |
| September 30, 2020 | 21.49M |
| June 30, 2020 | 16.74M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.53M |
| December 31, 2019 | 17.67M |
| September 30, 2019 | 21.96M |
| June 30, 2019 | 17.79M |
| March 31, 2019 | 9.788M |
| December 31, 2018 | 5.555M |
| September 30, 2018 | 19.68M |
| June 30, 2018 | 5.963M |
| March 31, 2018 | 1.572M |
| December 31, 2017 | 15.22M |
| September 30, 2017 | -1.728M |
| June 30, 2017 | 2.814M |
| March 31, 2017 | 1.147M |
| December 31, 2016 | 1.954M |
| September 30, 2016 | -1.186M |
| June 30, 2016 | 10.56M |
| March 31, 2016 | -3.811M |
| December 31, 2015 | 3.352M |
| September 30, 2015 | 6.588M |
| June 30, 2015 | 7.417M |
| March 31, 2015 | -2.304M |
| December 31, 2014 | 1.753M |
| September 30, 2014 | 6.328M |
| June 30, 2014 | 2.322M |
| March 31, 2014 | 7.999M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| BioLife Solutions, Inc. | 6.348M |
| Danaher Corp. | 1.534B |
| Liquidia Corp. | 80.24M |
| Harmony Biosciences Holdings, Inc. | 92.43M |
| Agilent Technologies, Inc. | 519.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -2.089M |
| Cash from Financing (Quarterly) | -6.20M |
| Free Cash Flow | 110.15M |
| Free Cash Flow Per Share (Quarterly) | 0.4714 |
| Free Cash Flow to Equity (Quarterly) | 23.38M |
| Free Cash Flow to Firm (Quarterly) | 28.85M |
| Free Cash Flow Yield | 1.10% |